APGE
Apogee Therapeutics, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $737.9K.
- InstitutionsBEARISH
Q3 2026: 1 added (0 new), 55 trimmed or exited.
- EstimatesFALLING
Current-quarter EPS estimate −$1.167 → −$1.250 over 90 days. 2 up, 3 down in 30 days.
- Short sellersSTEADY
Short interest −1.6% to 4.20M shares. 3.5 days to cover, ≈5.5% of shares.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | EXIT | $0.00 |
| BlackRock, Inc. | EXIT | $0.00 |
| MARSHALL WACE, LLP | EXIT | $0.00 |
| SOROS FUND MANAGEMENT LLC | EXIT | $0.00 |
| VANGUARD FIDUCIARY TRUST CO | EXIT | $0.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | EXIT | $0.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | EXIT | $0.00 |
| Verition Fund Management LLC | EXIT | $0.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2026| Date | Firm | Rating |
|---|---|---|
| Aug 13, 2026 | Truist Securities MAINTAIN | Hold |
| Aug 12, 2026 | BTIG DOWNGRADE | Neutral |
| Jun 24, 2026 | Stifel DOWNGRADE | Hold |
| Jun 24, 2026 | TD Cowen DOWNGRADE | Hold |
| Jun 24, 2026 | Guggenheim DOWNGRADE | Neutral |
| Jun 24, 2026 | Mizuho DOWNGRADE | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 6,743,321 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 10,370 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 340,855 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 51,166 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 7,657 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 47,758 sh |
Fairmount Funds Management LLC Director Sep 3, 2026 | TO ISSUER | 14,461 sh |
JONES WILLIAM A JR Director Sep 3, 2026 | TO ISSUER | 34,824 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$1.25 | -$1.27–-$1.23 | -8.2% | $0.00 |
| Next Q | -$1.37 | -$1.40–-$1.34 | -10.7% | $0.00 |
| Current FY | -$4.86 | -$4.93–-$4.79 | -10.1% | $0.00 |
| Next FY | -$5.20 | -$5.87–-$4.36 | -0.1% | $7.1M |
Short side
FINRA· Aug 31, 2026| Sep 2, 2026 | Deletion | Resumed |
SecBot reports
23 filings · 8 press releases · 11 bullish · 1 bearish · 1 mixed · 10 neutral- NEUTRAL 15-12GSep 14, 2026
Apogee Therapeutics has filed a Form 15-12G to terminate its SEC registration and suspend…
No actionable trading opportunity remains, APGE shares have been delisted and the merger with AbbVie is complete. Monitor for any residual distributions or tax-related filings from the merger…
- BULLISH 25-NSESep 3, 2026
Apogee Therapeutics has been acquired by AbbVie in a completed all-cash merger valued at…
The merger is complete and the stock will be delisted. Traders holding APGE shares should have already tendered them for the $135.11 cash consideration. There is no further trading opportunity in…
- BULLISH 8-KSep 3, 2026
Apogee Therapeutics has been acquired by AbbVie in a completed all-cash merger valued at…
The merger is complete and the stock will be delisted. Traders holding APGE shares should have already tendered them for the $135.11 cash consideration. Any remaining shares will be converted to the…
- BULLISH 8-KAug 11, 2026
Apogee Therapeutics stockholders voted overwhelmingly to approve the $135.11/share all-cash…
The shareholder vote removes the last major regulatory/approval hurdle for the AbbVie acquisition. The deal is now subject to remaining antitrust clearances (Australia ACCC) and customary closing…
All APGE filing & press-release reports (31)
- 15-12G reportSep 14, 2026
- 25-NSE reportSep 3, 2026
- 8-K reportSep 3, 2026
- 8-K reportAug 11, 2026
- 8-K reportAug 10, 2026
- PRESS-RELEASE reportAug 10, 2026
- INST-CLUSTER reportAug 6, 2026
- DEFA14A reportAug 3, 2026
- CLUSTER reportJul 10, 2026
- 8-K reportJun 22, 2026
- DEFA14A reportJun 26, 2026
- CLUSTER reportJun 24, 2026
- 8-K reportMay 27, 2026
- 8-K reportMay 27, 2026
- PRESS-RELEASE reportMay 27, 2026
- PRESS-RELEASE reportMay 27, 2026
- PRESS-RELEASE reportMay 26, 2026
- CLUSTER reportMay 15, 2026
- 144 reportMay 13, 2026
- 8-K reportMay 11, 2026
- PRESS-RELEASE reportMay 11, 2026
- CLUSTER reportMay 1, 2026
- DEFA14A reportApr 24, 2026
- 8-K reportApr 24, 2026
- CLUSTER reportApr 1, 2026
- CLUSTER reportApr 1, 2026
- PRESS-RELEASE reportMar 26, 2026
- PRESS-RELEASE reportMar 24, 2026
- PRESS-RELEASE reportMar 23, 2026
- PRESS-RELEASE reportMar 23, 2026
- PRESS-RELEASE reportMar 2, 2026